These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36821034)

  • 41. Association study between FSHR Ala307Thr and Ser680Asn variants and polycystic ovary syndrome (PCOS) in Northern Chinese Han women.
    Fu L; Zhang Z; Zhang A; Xu J; Huang X; Zheng Q; Cao Y; Wang L; Du J
    J Assist Reprod Genet; 2013 Jun; 30(5):717-21. PubMed ID: 23536150
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Raised plasminogen activator inhibitor-1 (PAI-1) is not an independent risk factor in the polycystic ovary syndrome (PCOS).
    Atiomo WU; Fox R; Condon JE; Shaw S; Friend J; Prentice AG; Wilkin TJ
    Clin Endocrinol (Oxf); 2000 Apr; 52(4):487-92. PubMed ID: 10762292
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The relationship between thyroid function and metabolic changes in Chinese women with polycystic ovary syndrome.
    Yin D; Ruan X; Tian X; Du J; Zhao Y; Cui Y; Li Y; Mueck AO
    Gynecol Endocrinol; 2017 Apr; 33(4):332-335. PubMed ID: 28051891
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gene variants associated with age at menopause are also associated with polycystic ovary syndrome, gonadotrophins and ovarian volume.
    Saxena R; Bjonnes AC; Georgopoulos NA; Koika V; Panidis D; Welt CK
    Hum Reprod; 2015 Jul; 30(7):1697-703. PubMed ID: 25994816
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Case-Control Study of the Luteinizing Hormone Level in Luteinizing Hormone Receptor Gene (rs2293275) Polymorphism in Polycystic Ovarian Syndrome Females.
    Atoum MF; Alajlouni MM; Alzoughool F
    Public Health Genomics; 2022 Mar; ():1-9. PubMed ID: 35350019
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A study on lipoprotein-a and PAI-1 in women with polycystic ovary syndrome.
    Shah AK; Yadav BK; Suri A; Shah AK
    Horm Mol Biol Clin Investig; 2022 Sep; 43(3):357-361. PubMed ID: 35439403
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
    Wu J; Zhu Y; Jiang Y; Cao Y
    Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic polymorphisms in Pakistani women with polycystic ovary syndrome.
    Liaqat I; Jahan N; Krikun G; Taylor HS
    Reprod Sci; 2015 Mar; 22(3):347-57. PubMed ID: 25100445
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic variations of follicle stimulating hormone receptor are associated with polycystic ovary syndrome.
    Gu BH; Park JM; Baek KH
    Int J Mol Med; 2010 Jul; 26(1):107-12. PubMed ID: 20514429
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H; Tanir HM; Yildiz Z
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome.
    Taylor AE; McCourt B; Martin KA; Anderson EJ; Adams JM; Schoenfeld D; Hall JE
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2248-56. PubMed ID: 9215302
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analyses of risk factors for polycystic ovary syndrome complicated with non-alcoholic fatty liver disease.
    Zhang J; Hu J; Zhang C; Jiao Y; Kong X; Wang W
    Exp Ther Med; 2018 May; 15(5):4259-4264. PubMed ID: 29725371
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preliminary study showing no association between G238A (rs361525) tumor necrosis factor-α (TNF-α) gene polymorphism and its serum level, hormonal and biochemical aspects of polycystic ovary syndrome.
    Kordestani F; Mazloomi S; Mortazavi Y; Mazloomzadeh S; Fathi M; Rahmanpour H; Nazarian A
    BMC Med Genet; 2018 Aug; 19(1):149. PubMed ID: 30134857
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reproductive hormone metabolism in women with infertility due to polycystic ovary syndrome depending on the constitutional body types.
    Khmil M; Khmil S; Marushchak M; Halnykina S; Khmil A
    Pol Merkur Lekarski; 2020 Jun; 48(285):152. PubMed ID: 32564037
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum uric acid/creatinine ratio and free androgen index are synergistically associated with increased risk of polycystic ovary syndrome in obese women.
    El-Eshmawy MM; Ibrahim A; Bahriz R; Shams-Eldin N; Mahsoub N
    BMC Endocr Disord; 2022 Dec; 22(1):315. PubMed ID: 36514085
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pilot study on evaluation and determination of the prevalence of Polycystic Ovarian Syndrome (PCOS) associated gene markers in the South Indian population.
    Ramanathan B; Murugan J; Velayutham K
    Indian J Endocrinol Metab; 2021; 25(6):551-558. PubMed ID: 35355907
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of selected genetic polymorphisms in polycystic ovary syndrome in Sri Lankan women using low cost genotyping techniques.
    Branavan U; Muneeswaran K; Wijesundera S; Jayakody S; Chandrasekharan V; Wijeyaratne C
    PLoS One; 2018; 13(12):e0209830. PubMed ID: 30596735
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adipocyte and steroidogenic cell cross-talk in polycystic ovary syndrome.
    de Medeiros SF; Rodgers RJ; Norman RJ
    Hum Reprod Update; 2021 Jun; 27(4):771-796. PubMed ID: 33764457
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association between ACE gene I/D polymorphisms and hyperandrogenism in women with polycystic ovary syndrome (PCOS) and controls.
    Sun J; Fan H; Che Y; Cao Y; Wu X; Sun HX; Liang F; Yi L; Wang Y
    BMC Med Genet; 2009 Jul; 10():64. PubMed ID: 19602270
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Genetic aspects of polycystic ovary syndrome].
    Jakubowski L
    Endokrynol Pol; 2005; 56(3):285-93. PubMed ID: 16350721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.